Showing results (321-330 of 642) with videos related to

Sort By:
Pageof 65
Cancer Causes & Control : CCC|October 7, 2005
Using data to motivate action: the need for high quality, an effective presentation, and an action context for decision-makingBruce L Black, Rebecca Cowens-Alvarado, Susan Gershman, et al.
Histology and Histopathology|April 1, 1987
Anti-platelet agents reduce morphological changes of chronic hypoxic pulmonary hypertensionI M Keith, J A Will, R J Huxtable, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 1, 1993
Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressureV Hampl, S L Archer, D P Nelson, et al.
The American Journal of Cardiology|January 1, 1983
Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertensionT E Young, L J Lundquist, E Chesler, et al.
Advances in Experimental Medicine and Biology|June 13, 2000
Molecular identification of O2 sensors and O2-sensitive potassium channels in the pulmonary circulationS L Archer, E K Weir, H L Reeve, et al.
Journal of Applied Physiology|April 1, 1976
Failure of histamine antagonists to prevent hypoxic pulmonary vasoconstriction in dogsA Tucker, E K Weir, J T Reeves, et al.
Biochemical and Biophysical Research Communications|August 30, 1989
Hydroxylamine is a vasorelaxant and a possible intermediate in the oxidative conversion of L-arginine to nitric oxideE G DeMaster, L Raij, S L Archer, et al.
The American Journal of Cardiology|May 1, 1987
Exercise thallium testing in ventricular preexcitationS Archer, C Gornick, F Grund, et al.
Pageof 65